TL;DR
Tuberculosis (TB) rates in China have dramatically decreased since 1990, but progress has slowed, and the epidemic is increasingly affecting older adults due to population aging. While improved public health interventions are the main driver of this decline, demographic shifts and evolving risk factors like smoking, alcohol, and metabolic disorders require adaptive control strategies to meet future elimination goals.
What Problem Does This Paper Address?
Despite significant global efforts, tuberculosis (TB) remains a major public health challenge. The World Health Organization's End TB Strategy aims for ambitious reductions in TB incidence and mortality by 2035, but current progress is insufficient, especially in high-burden countries facing complex demographic and health system challenges. China, a major contributor to the global TB burden, has seen substantial declines in TB rates. However, understanding the long-term trends, the specific drivers of these declines, and how demographic changes and evolving risk factors are reshaping the epidemic is crucial for developing effective, targeted interventions to meet elimination targets. Previous studies often focused on temporal trends without fully integrating demographic and risk factor analyses, and many were limited by older data, not capturing the impact of recent events like the COVID-19 pandemic.
Methods
This study employed a multi-faceted approach to analyze TB trends and determinants in China from 1990 to 2023:
- Trend Analysis: Age-standardized rates (ASRs) for incidence, mortality, and disability-adjusted life years (DALYs) were calculated. The Estimated Annual Percentage Change (EAPC) was used to quantify the magnitude and direction of long-term trends. Segmented analyses were performed to examine trends before and after 2021, particularly in light of the COVID-19 pandemic.
- Age-Period-Cohort (APC) Modeling: This statistical technique was used to disentangle the independent effects of age, calendar period, and birth cohort on TB burden. It helps understand how different generations and time periods contribute to observed trends.
- Demographic Decomposition: This method was used to quantify the relative contributions of population growth, population aging, and changes in age-specific rates to the overall changes in TB cases, deaths, and DALYs. This helps separate the impact of demographic shifts from actual changes in disease risk.
- Comparative Risk Assessment (CRA): This framework, using population-attributable fractions (PAFs), was employed to quantify the burden of TB attributable to specific behavioral and metabolic risk factors, including smoking, high alcohol consumption, high fasting plasma glucose, and high body-mass index (BMI).
Datasets
The primary dataset used in this study was the Global Burden of Disease Study 2023 (GBD 2023). This comprehensive dataset, coordinated by the Institute for Health Metrics and Evaluation (IHME), provides standardized annual estimates of incidence, mortality, and DALYs for 204 countries and territories from 1990 to 2023. The data was accessed through the GBD Results Tool.
Key Insights and Ideas
- The "Slowing Down" of Progress: While TB rates have plummeted, the rate of decline has slowed since 2015, indicating that current efforts may not be sufficient to meet the ambitious 2035 End TB Strategy targets.
- The Aging Epidemic: Population aging is a significant factor, with the burden of TB increasingly shifting towards older adults. This suggests that latent TB infections from earlier in life may be reactivating in older individuals, a pattern seen in other aging populations.
- Persistent Sex Disparities: Males consistently experience higher TB rates than females. This is strongly linked to higher prevalence of behavioral risk factors like smoking and alcohol use in men.
- Behavioral vs. Metabolic Risks: Smoking and alcohol use remain the dominant attributable risk factors for TB burden, particularly in males. However, metabolic factors like high fasting plasma glucose and high BMI are also contributing, and their relative importance may be growing, especially in aging populations with increasing rates of comorbidities.
- COVID-19's Ripple Effect: The study notes a modest rebound in incidence after 2021, which is likely due to delayed diagnosis and service disruptions during the COVID-19 pandemic, rather than a resurgence of transmission.
Key Results
- Dramatic Declines: Between 1990 and 2023, age-standardized incidence, mortality, and DALY rates in China declined by approximately 73.24%, 94.00%, and 92.40%, respectively.
- Incidence Rebound: After a steady decline until 2021, age-standardized incidence rates showed a modest increase of 1.10% per year from 2021 to 2023.
- Aging Population Impact: The proportion of TB deaths among individuals aged ≥60 years increased from 50.27% in 1990 to 70.67% in 2023.
- Male Burden: In 2023, males accounted for 65.02% of new TB cases and 73.59% of TB deaths. The male-to-female ratio for age-standardized incidence was approximately 1.65:1, and for mortality, it was approximately 2.98:1.
- Risk Factor Dominance: Smoking was the leading attributable risk factor for TB mortality and DALYs, followed by high alcohol use.
- Demographic vs. Epidemiological Change: While improvements in age-specific TB rates were the primary driver of long-term reductions (accounting for over 200% of the decline in incidence, mortality, and DALYs), demographic shifts, particularly population aging, partially offset these gains (contributing to approximately -60% of the decline).
Limitations and Future Work
The authors acknowledge several limitations:
- GBD Data Reliance: GBD estimates are derived from statistical modeling to address data gaps, meaning residual uncertainty may exist, especially for age-specific and risk-attributable estimates.
- Lack of Subnational Heterogeneity: The analysis was conducted at the national level, and does not capture potential variations in TB burden across different provinces or urban-rural settings within China.
- Stable Exposure-Outcome Assumptions: The comparative risk assessment framework assumes stable relationships between exposures and outcomes, which may not fully account for complex interactions among demographic, behavioral, and metabolic factors.
- No Distinction by TB Type: The study did not differentiate between drug-susceptible and drug-resistant TB, or between HIV-associated and non-HIV-associated cases, which can have distinct epidemiologic patterns.
Future work should focus on developing strategies that integrate TB management with chronic disease care, strengthen health system resilience, and prioritize high-risk populations (especially older adults with comorbidities and close contacts of infectious TB cases) for screening and preventive interventions. Addressing the evolving risk structures and demographic transitions will be key to achieving TB elimination.
Summary updated